Correction to “Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases”
Year: 2025
Type: erratum
Abstract: Torrandell-Haro G, Branigan GL, Vitali F, Geifman N, Zissimopoulos JM, Brinton RD. Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseases. Alzheimer's Dement. 2020; 6:e12108. In Figure 2B, there was an error in the table where the values for risk reduction (RR) (95% confidence interval [CI]) of simvastatin for dementia and multiple Sclerosis (MS) were mistakenly duplicated. The correct value for simvastatin and risk of dementia is 0.59 (0.56–0.62), whereas the risk of MS was correctly presented as 0.45 (0.33–0.61). The correction in the table within Figure 2B does not change the statistical significance. Figure 2B has been updated to reflect the correct RR (95% CI) value for dementia associated with simvastatin and to address a publication-related adjustment to the X axis of Figure 2B. We sincerely apologize for the error in the RR value for dementia in the table within Figure 2B.
DOI: 10.1002/trc2.70027
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,540
OpenAlex ID: W4410501621